VRTX — VERTEX PHARMACEUTICALS INC

Ownership history in HSBC HOLDINGS PLC  ·  139 quarters on record

AI Ownership Summary

HSBC HOLDINGS PLC reported VERTEX PHARMACEUTICALS INC (VRTX) in 139 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 0.26% in 2024 Q2. The latest visible filing shows VRTX at 0.16% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this VRTX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was HSBC HOLDINGS PLC's position in VERTEX PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

VRTX was reported at 0.16% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.26% in 2024 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

VRTX stock page HSBC HOLDINGS PLC fund profile HSBC HOLDINGS PLC full holdings
How HSBC HOLDINGS PLC held VRTX — position size vs. price
% of Fund (quarterly)    VRTX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 25 quarters  ▾
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 630,289 -7,043 -1.1% 0.16% $285.9M 2026-02-14 (Est.) $491.47
2025 Q3 ADDED 637,332 +625,132 +5124.0% 0.14% $249.5M 2025-11-13 $434.52
2025 Q3 REDUCED 12,200 -3,500 -22.3% 0.00% $4.8M 2025-11-13 $434.52
2025 Q3 REDUCED 15,700 -626,261 -97.6% 0.00% $6.1M 2025-11-13 $434.52
2025 Q2 ADDED 641,961 +630,161 +5340.3% 0.17% $285.7M 2025-08-13 $395.92
2025 Q2 REDUCED 11,800 -3,100 -20.8% 0.00% $5.2M 2025-08-13 $395.92
2025 Q2 REDUCED 14,900 -829,775 -98.2% 0.00% $6.6M 2025-08-13 $395.92
2025 Q1 ADDED 844,675 +831,475 +6299.1% 0.25% $408.6M 2025-05-14 $421.16
2025 Q1 ADDED 13,200 +2,500 +23.4% 0.00% $6.3M 2025-05-14 $421.16
2025 Q1 REDUCED 10,700 -863,055 -98.8% 0.00% $5.2M 2025-05-14 $421.16
2024 Q4 ADDED 873,755 +855,455 +4674.6% 0.20% $351.7M 2025-02-14 $459.00
2024 Q4 ADDED 18,300 +6,400 +53.8% 0.00% $7.4M 2025-02-14 $459.00
2024 Q4 REDUCED 11,900 -843,116 -98.6% 0.00% $4.8M 2025-02-14 $459.00
2024 Q3 ADDED 855,016 +838,216 +4989.4% 0.23% $397.4M 2024-11-14 $483.96
2024 Q3 ADDED 16,800 +5,500 +48.7% 0.00% $7.8M 2024-11-14 $483.96
2024 Q3 REDUCED 11,300 -893,442 -98.8% 0.00% $5.3M 2024-11-14 $483.96
2024 Q2 ADDED 904,742 +887,942 +5285.4% 0.26% $425.1M 2024-08-12 $464.51
2024 Q2 REDUCED 16,800 -14,100 -45.6% 0.00% $8.0M 2024-08-12 $464.51
2024 Q2 REDUCED 30,900 -775,042 -96.2% 0.01% $14.6M 2024-08-12 $464.51
2024 Q1 ADDED 805,942 +764,942 +1865.7% 0.23% $336.8M 2024-05-15 $437.49
2024 Q1 ADDED 41,000 +3,600 +9.6% 0.01% $17.1M 2024-05-15 $437.49
2024 Q1 REDUCED 37,400 -577,269 -93.9% 0.01% $15.6M 2024-05-15 $437.49
2023 Q4 ADDED 614,669 +567,669 +1207.8% 0.22% $250.2M 2024-02-12 $418.53
2023 Q4 ADDED 47,000 +24,100 +105.2% 0.02% $19.2M 2024-02-12 $418.53
2023 Q4 REDUCED 22,900 -537,907 -95.9% 0.01% $9.3M 2024-02-12 $418.53
114 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding VRTX

As of 2026 Q1 — sorted by position size

Andrew Hill Investment Advisors, Inc. 3Y 4.76% Sivik Global Healthcare LLC 3Y 7Y 3.39% Heirloom Wealth Management 3Y 1.89% MOODY LYNN LIEBERSON & WALKER, LLC 3Y 7Y 1.44% ATWOOD & PALMER INC 3Y 7Y 1.4% LVM CAPITAL MANAGEMENT LTD/MI 3Y 7Y 1.09% Murphy & Mullick Capital Management Corp 1.04% Third View Private Wealth, LLC 1.03% BEACON INVESTMENT ADVISORY SERVICES, INC. 3Y 7Y 1.03% Hamrick Investment Counsel, llc 1.01%

FAQ About HSBC HOLDINGS PLC and VRTX

These are the practical questions this page is built to answer before you even open the full history table.

How long has HSBC HOLDINGS PLC reported owning VRTX?

HSBC HOLDINGS PLC reported VRTX across 25 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported VRTX position in HSBC HOLDINGS PLC's portfolio?

The largest reported portfolio weight for VRTX was 0.26% in 2024 Q2.

What is the latest reported VRTX position on this page?

The most recent filing on this page is 2025 Q4, when HSBC HOLDINGS PLC reported 630,289 shares, equal to 0.16% of portfolio, with an estimated market value of $285.9M.

What does the chart on this VRTX ownership page compare?

The chart compares HSBC HOLDINGS PLC's quarterly VRTX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to HSBC HOLDINGS PLC Holdings